Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C in state correctional facilities

A Spaulding1, C Greene, K Davidson

  • 1Division of Infectious Disease, Rhode Island Hospital, Providence, USA. Anne_Spaulding_MD@brown.edu

Preventive Medicine
|February 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computed tomography, ultrasound and fluoroscopy guidance in intra-articular sacroiliac joint injections: A systematic review.

Radiography (London, England : 1995)·2026
Same author

Guidance for the gastrointestinal evaluation and management of iron deficiency in Sub-Saharan Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024
Same author

The role of pandemic planning in the management of COVID-19 in England from an infection prevention and control perspective: results of a national survey.

Public health·2023
Same author

Effects of Presbyphagia on Oropharyngeal Swallowing Observed during Modified Barium Swallow Studies.

The journal of nutrition, health & aging·2022
Same author

Lessons for Australia - Commentary on "Temporomandibular disorders: Priorities for research and care".

Australian dental journal·2022
Same author

Trade-offs between succulent and non-succulent epiphytes underlie variation in drought tolerance and avoidance.

Oecologia·2022
Same journal

Behavioral economic demand analysis: A multidimensional framework for understanding drug reinforcement and tobacco science.

Preventive medicine·2026
Same journal

Corrigendum to 'Differential associations of objective hearing loss and subjective hearing difficulty with depressive symptom profiles: A nationwide population-based study in Korea' [Preventive Medicine 210 (2026) 108620].

Preventive medicine·2026
Same journal

Adverse childhood experiences and household firearm ownership: A large-scale analysis of specific risk factors among 15,771 adults from four U.S. states.

Preventive medicine·2026
Same journal

Worldwide prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes: A systematic review and meta-analysis.

Preventive medicine·2026
Same journal

Employment insecurity and binge drinking in the United States: Implications of unemployment insurance.

Preventive medicine·2026
Same journal

The dual use dilemma: Is it better to have tried and failed to quit smoking with e-cigarettes or to have never tried e-cigarettes at all?

Preventive medicine·2026
See all related articles

Few US correctional facilities screen or treat hepatitis C (HCV). A survey and model suggest treating HCV in prisons is feasible and a worthwhile public health investment.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Correctional Medicine

Background:

  • Limited research exists on hepatitis C (HCV) screening and treatment within US correctional facilities.
  • Correctional facilities house a significant population at risk for HCV infection.

Purpose of the Study:

  • To assess the current practices of screening and treating hepatitis C (HCV) in US state correctional facilities.
  • To evaluate the feasibility and cost-effectiveness of HCV treatment within the prison system.

Main Methods:

  • A survey was distributed to medical directors of state correctional facilities nationwide.
  • A feasibility model was developed using screening criteria from California and Rhode Island to estimate treatment eligibility and costs.

Main Results:

Related Experiment Videos

  • 36 states responded, representing 77% of inmates; only Colorado reported routine screening.
  • California's 1994 study found 39.4% of male inmates were hepatitis C antibody positive.
  • 73% of facilities sometimes consider interferon treatment; only 4 states have a standard protocol.

Conclusions:

  • Correctional facilities present a viable setting for hepatitis C (HCV) treatment.
  • Addressing substance abuse alongside HCV treatment in incarcerated individuals is a sound public health strategy.
  • Investing in HCV treatment for eligible inmates is a justifiable use of public health resources.